03/07/2025
2:07 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/20/2025
9:57 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
02/03/2025
3:40 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
4:10 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
8:24 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
01/22/2025
3:32 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
3:12 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:32 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:27 AM | Javitt Jonathan C (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
12:44 PM | ABRAMS MICHAEL S (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2024
8:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for NRXPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
11/15/2024
4:24 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:21 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/31/2024
7:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
3:52 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:53 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:18 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form DEF 14A | |
08/20/2024
3:38 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:27 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:39 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
4:15 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:58 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
6:37 PM | McBride Dennis (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
4:03 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:26 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:46 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-K/A | |
04/19/2024
4:10 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
9:08 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
04/18/2024
7:21 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
04/15/2024
4:22 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:13 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
04/15/2024
5:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
04/02/2024
5:01 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:18 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
4:09 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:08 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form DEFA14A | |
